Kerget, B. Et Al. 2022. Evaluation of serum YKL-40 level among clinical risk scores for early mortality in acute pulmonary thromboembolism.. Clinical biochemistry , vol.108, no.1 , 20-26.

Kerget, B., Özkan, H. B., Afşin, D. E., Koçak, A. O., Laloglu, E., Uçar, E. Y., ... Sağlam, L.(2022). Evaluation of serum YKL-40 level among clinical risk scores for early mortality in acute pulmonary thromboembolism.. Clinical biochemistry , vol.108, no.1, 20-26.

Kerget, Buğra Et Al. "Evaluation of serum YKL-40 level among clinical risk scores for early mortality in acute pulmonary thromboembolism.," Clinical biochemistry , vol.108, no.1, 20-26, 2022

Kerget, Buğra Et Al. "Evaluation of serum YKL-40 level among clinical risk scores for early mortality in acute pulmonary thromboembolism.." Clinical biochemistry , vol.108, no.1, pp.20-26, 2022

Kerget, B. Et Al. (2022) . "Evaluation of serum YKL-40 level among clinical risk scores for early mortality in acute pulmonary thromboembolism.." Clinical biochemistry , vol.108, no.1, pp.20-26.

@article{article, author={Buğra KERGET Et Al. }, title={Evaluation of serum YKL-40 level among clinical risk scores for early mortality in acute pulmonary thromboembolism.}, journal={Clinical biochemistry}, year=2022, pages={20-26} }